Skip to main content
Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.550
-0.060 (-3.73%)
Dec 20, 2024, 4:00 PM EST - Market closed

Ikena Oncology Revenue

Ikena Oncology had revenue of $659.00K in the twelve months ending September 30, 2024, down -95.28% year-over-year. In the year 2023, Ikena Oncology had annual revenue of $9.16M, down -41.35%.

Revenue (ttm)
$659.00K
Revenue Growth
-95.28%
P/S Ratio
113.28
Revenue / Employee
$15,326
Employees
43
Market Cap
74.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.16M-6.46M-41.35%
Dec 31, 202215.62M-15.37M-49.59%
Dec 31, 202130.99M21.79M237.01%
Dec 31, 20209.19M-4.56M-33.15%
Dec 31, 201913.75M12.76M1,289.19%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
23andMe Holding Co. 193.26M
InspireMD 6.82M
Adlai Nortye 5.00M
I-Mab 3.31M
Entera Bio 99.00K
Revenue Rankings

IKNA News

More News